University of Iowa Hospital & Clinic
Welcome,         Profile    Billing    Logout  
 4 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Robinson, Jennifer
SIL02, NCT03142568: Safety of Sildenafil in Premature Infants

Recruiting
2
120
Canada, US
Sildenafil, Revatio, Placebo, sugar water
University of North Carolina, Chapel Hill, Duke University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), The Emmes Company, LLC
Bronchopulmonary Dysplasia
02/25
04/25
CBD, NCT04831294: Effects of Cannabidiol () on the Brain

Active, not recruiting
N/A
15
US
Cannabidiol, CBD, Placebo
Auburn University, Folium Biosciences, FutureCeuticals
CBD, Fear, Inhibition
05/22
12/23
NCT05206422: DORAYA-HF Early Feasibility Study

Recruiting
N/A
30
US
Doraya Catheter
Revamp Medical Inc.
Acute Decompensated Heart Failure
10/25
12/25
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29
NCT05438979: Joint Health Study

Recruiting
N/A
300
US
Placebo, Calcium Fructoborate, CFB
Auburn University
Effect of Drug
06/24
12/24
NCT06540118: Food is Medicine for Patients with Heart Failure

Recruiting
N/A
60
US
15 Medically Tailored Meals (MTM) per week, 14 Medically Tailored Meals (MTM) per week
University of California, San Diego, Stanford University
Heart Failure, Heart Failure，Congestive, Heart Diseases
06/25
06/25
Correia, Marcelo L
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Active, not recruiting
3
2749
Europe, US, RoW
Orforglipron, LY3502970, Insulin Glargine
Eli Lilly and Company
Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
09/25
01/26
NCT04861571: Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD

Recruiting
N/A
20
US
Dietary intervention with very low calorie diet (VLCD), VLCD Arm, Control Arm
University of Iowa
NAFLD
07/26
12/26

Download Options